Skip to content
healthcare.dev

Ganciclovir

NDC 51817-171, ganciclovir sodium, injection, solution, from Pharmascience Inc..

Product NDC
51817-171
Status
Listed
Labeler
Pharmascience Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207645
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51817-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GANCICLOVIR SODIUM500 mg/10mL

Pharmacologic classes

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog Antiviral [EPC]; Nucleoside Analog [EXT]

Package NDCNDC-11Package
51817-171-015181701710125 VIAL in 1 CARTON (51817-171-01) / 10 mL in 1 VIAL
51817-171-02518170171021 VIAL in 1 CARTON (51817-171-02) / 10 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3059c2da-d4a7-4aea-828c-20e671cb875c

Use it

Look up 51817-171 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51817-171 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51817-171. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.